CHERYL KETELSEN: Open Payments
NPI 1770938532 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 35 payments from 11 companies in 2025. Trend: 2023 $822 · 2024 $1,413 · 2025 $1,401
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $215 |
| Lilly USA, LLC | 4 | $190 |
| E.R. Squibb & Sons, L.L.C. | 4 | $183 |
| PFIZER INC. | 3 | $170 |
| Janssen Biotech, Inc. | 4 | $140 |
| LEO Pharma Inc. | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $106 |
| Arcutis Biotherapeutics, Inc. | 1 | $103 |
| Biofrontera Inc. | 3 | $69 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
Products named: SKYRIZI, Sotyktu, CIBINQO, TREMFYA, EBGLYSS, DUPIXENT, Zoryve, ANZUPGO.
Industry payments across CA — which companies pay providers there.
